Research Article
Upregulation of lnc-ZNF281 Inhibits the Progression of Glioma via the AKT/GSK-3β/β-Catenin Signaling Pathway
Figure 1
Expression levels of lnc-ZNF281 were reduced in glioma tissues. (a) qRT-PCR results indicated lnc-ZNF281 had a low expression level in glioma tissues compared to normal brain tissues. (b) qRT-PCR results indicated that the expression level of lnc-ZNF281 in glioma cells increased significantly after lentiviral transfection. .
(a) |
(b) |